StemoniX Overview

  • Founded
  • 2014
Founded
  • Status
  • Private
  • Employees
  • 31
Employees
  • Latest Deal Type
  • M&A
  • (Announced)
  • Investors
  • 20

StemoniX General Information

Description

Developer of a human-induced cardiac screening platform intended to improve and accelerate the process of neurotoxicity research and drug screening. The company's platform creates new cell-based disease models, and operationalizes custom human iPSC disease models at large scale for high-throughput screening, enabling scientists to quickly and economically conduct research with improved outcomes in a simplified workflow.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Pharmaceuticals
Primary Office
  • 13300 67th Avenue North
  • Maple Grove, MN 55311
  • United States
+1 (855) 000-0000

StemoniX Timeline

2017201820192020
Financing RoundFinancing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

StemoniX Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
15. Merger/Acquisition 24-Aug-2020 000.00 Announced Generating Revenue
14. Later Stage VC 15-May-2020 00000 000.00 Completed Generating Revenue
13. Debt - PPP 10-Apr-2020 000.00 Completed Generating Revenue
12. Early Stage VC (Series B) 23-Oct-2019 000.00 000.00 Completed Generating Revenue
11. Early Stage VC 11-Oct-2019 00.000 000.00 Completed Generating Revenue
10. Early Stage VC 06-Sep-2018 00.000 000.00 Completed Generating Revenue
9. Early Stage VC (Series A) 10-Mar-2017 00.000 00.000 Completed Generating Revenue
8. Seed Round 06-Oct-2016 00.00 00.000 Completed Generating Revenue
7. Accelerator/Incubator 03-Oct-2016 $80K $3.42M Completed Generating Revenue
6. Grant 23-Sep-2016 $80K $3.37M Completed Generating Revenue
To view StemoniX’s complete valuation and funding history, request access »

StemoniX Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of a human-induced cardiac screening platform intended to improve and accelerate the process of neurotoxicity
Biotechnology
Maple Grove, MN
31 As of 2020
000.00
000000&0 000.00

00000000

aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea com
0000 000000000
Cambridge, United Kingdom
00 As of 0000
00.000
0000000000 00.000

000 0000

se cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in c
0000 000000000
Seattle, WA
00 As of 0000
000.00
0000000000 0 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

StemoniX Competitors (22)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
DefiniGEN Venture Capital-Backed Cambridge, United Kingdom 00 00.000 0000000000 00.000
000 0000000000000 Venture Capital-Backed Seattle, WA 00 000.00 0000000000 0 000.00
0000000 Venture Capital-Backed Villaz-Saint-Pierre, Switzerland 0000
00000000 Formerly VC-backed Schlieren, Switzerland 00 000.00 0000000000 0 000.00
0000 00000000000 Private Equity-Backed Cambridgeshire, United Kingdom 00 00.000 0000000 0000 00.000
You’re viewing 5 of 22 competitors. Get the full list »

StemoniX Executive Team (6)

Name Title Board Seat Contact Info
Ping Yeh Co-Founder, Chief Executive Officer & Board Member
Andrew LaFrence Chief Financial Officer & Chief Operating Officer
Robert Petcavich Ph.D Co-Founder, Chief Science Officer & Board Member
Ryan Gordon Vice President of Business Development & Commercialization
You’re viewing 4 of 6 executive team members. Get the full list »

StemoniX Board Members (8)

Name Representing Role Since
Kevin Gunderson StemoniX Board Member 000 0000
Marcus Boehm StemoniX Board Member 000 0000
Patrick O'Shaughnessy JD Brightstone Venture Capital Board Member 000 0000
Paul Hansen Gopher Angels Board Member 000 0000
Ping Yeh StemoniX Co-Founder, Chief Executive Officer & Board Member 000 0000
You’re viewing 5 of 8 board members. Get the full list »

StemoniX Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

StemoniX Investors (20)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Bascom Ventures Venture Capital Minority 000 0000 000000 0
Chestnut Street Ventures Venture Capital Minority 000 0000 000000 0
Exponential Venture Capital Minority 000 0000 000000 0
ImpactAssets Impact Investing Minority 000 0000 000000 0
Keshif Ventures Angel Group Minority 000 0000 000000 0
You’re viewing 5 of 20 investors. Get the full list »

StemoniX Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000 0000000 (000 03-Dec-2019 00000 0000000 Drug Discovery 0000 000
To view StemoniX’s complete investments history, request access »